Open-source automated insulin delivery systems in children and adolescents

被引:0
作者
Braune, Katarina [1 ]
机构
[1] Charite Univ Med Berlin, Inst Med Informat, Med Data Sci, Campus Charite Mitte, Charitepl 1, D-10117 Berlin, Germany
来源
DIABETOLOGIE | 2024年 / 20卷 / 07期
关键词
Do-it-yourself; Diabetes technology; Infusion systems; Type; 1; diabetes; Medical ethics;
D O I
10.1007/s11428-024-01221-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This article discusses the development and use of open-source automated insulin delivery (AID) systems for children and adolescents with diabetes. These technologies provide much-needed alternatives to commercial products, particularly if approved systems are unavailable or insufficiently adapted to the specific needs of the user. Open-source AID systems such as Loop, OpenAPS, AndroidAPS, and iAPS are developed by a committed society of persons with diabetes and their relatives. They offer do-it-yourself approaches to personalized diabetes treatment based on available insulin pumps and systems for continuous glucose monitoring. Recent studies have demonstrated that both commercial and open-source AID systems enhance clinical outcomes and quality of life. Despite the lack of regulatory approval in Europe, these systems represent an effective treatment option for children and adolescents with diabetes, underscored by many positive experiences in clinical practice and users' everyday life. The article also addresses the ethical and legal challenges of employing open-source technologies in pediatric diabetology. Despite the challenges associated with using medical software without regulatory clearance, well-informed and well-supported application of these systems can deliver effective results. The article stresses the importance of collaboration among people with diabetes, their families, and medical professionals to ensure the success and safely of treatment and to boost the empowerment and autonomy of persons with diabetes.
引用
收藏
页码:792 / 798
页数:7
相关论文
共 33 条
  • [1] [Anonymous], DTSCH DIABETES GESEL
  • [2] Area deprivation and demographic factors associated with diabetes technology use in adults with type 1 diabetes in Germany
    Auzanneau, Marie
    Eckert, Alexander J.
    Meyhoefer, Sebastian M.
    Heni, Martin
    Gillessen, Anton
    Schwettmann, Lars
    Jehle, Peter M.
    Hummel, Michael
    Holl, Reinhard W.
    DPV Initiative
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [3] The First Regulatory Clearance of an Open-Source Automated Insulin Delivery Algorithm
    Braune, Katarina
    Hussain, Sufyan
    Lal, Rayhan
    [J]. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2023, : 1139 - 1141
  • [4] Emotional and Physical Health Impact in Children and Adolescents and Their Caregivers Using Open-source Automated Insulin Delivery: Qualitative Analysis of Lived Experiences
    Braune, Katarina
    Krug, Niklas
    Knoll, Christine
    Ballhausen, Hanne
    Thieffry, Axel
    Chen, Yanbing
    O'Donnell, Shane
    Raile, Klemens
    Cleal, Bryan
    [J]. JOURNAL OF MEDICAL INTERNET RESEARCH, 2022, 24 (07)
  • [5] Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals
    Braune, Katarina
    Lal, Rayhan A.
    Petruzelkova, Lenka
    Scheiner, Gary
    Winterdijk, Per
    Schmidt, Signe
    Raimond, Linda
    Hood, Korey K.
    Riddell, Michael C.
    Skinner, Timothy C.
    Raile, Klemens
    Hussain, Sufyan
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (01) : 58 - 74
  • [6] Why #WeAreNotWaiting-Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey
    Braune, Katarina
    Gajewska, Katarzyna Anna
    Thieffry, Axel
    Lewis, Dana Michelle
    Froment, Timothee
    O'Donnell, Shane
    Speight, Jane
    Hendrieckx, Christel
    Schipp, Jasmine
    Skinner, Timothy
    Langstrup, Henriette
    Tappe, Adrian
    Raile, Klemens
    Cleal, Bryan
    [J]. JOURNAL OF MEDICAL INTERNET RESEARCH, 2021, 23 (06)
  • [7] Equity in type 1 diabetes technology and beyond: where are we in 2022?
    Burckhardt, Marie-Anne
    Addala, Ananta
    de Bock, Martin
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [8] Interviews with Indigenous Maori with type 1 diabetes using open-source automated insulin delivery in the CREATE randomised trial
    Burnside, Mercedes
    Haitana, Tracy
    Crocket, Hamish
    Lewis, Dana
    Meier, Renee
    Sanders, Olivia
    Jefferies, Craig
    Faherty, Ann
    Paul, Ryan
    Lever, Claire
    Price, Sarah
    Frewen, Carla
    Jones, Shirley
    Gunn, Tim
    Wheeler, Benjamin J.
    Pitama, Suzanne
    de Bock, Martin
    Lacey, Cameron
    [J]. JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2023, 22 (01) : 861 - 871
  • [9] Inequity in access to continuous glucose monitoring and health outcomes in paediatric diabetes, a case for national continuous glucose monitoring funding: a cross-sectional population study of children with type 1 diabetes in New Zealand
    Burnside, Mercedes J.
    Williman, Jonathan A.
    Davies, Hannah M.
    Jefferies, Craig A.
    Paul, Ryan G.
    Wheeler, Benjamin J.
    Wiltshire, Esko J.
    Anderson, Yvonne C.
    de Bock, Martin I.
    [J]. LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 31
  • [10] Open-Source Automated Insulin Delivery in Type 1 Diabetes
    Burnside, Mercedes J.
    Lewis, Dana M.
    Crocket, Hamish R.
    Meier, Renee A.
    Williman, Jonathan A.
    Sanders, Olivia J.
    Jefferies, Craig A.
    Faherty, Ann M.
    Paul, Ryan G.
    Lever, Claire S.
    Price, Sarah K. J.
    Frewen, Carla M.
    Jones, Shirley D.
    Gunn, Tim C.
    Lampey, Christina
    Wheeler, Benjamin J.
    de Bock, Martin, I
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (10) : 869 - 881